Analysts at BNP Paribas Exane downgraded their ratings on three major oil companies due to an expected further decline in ...
Exxon Mobil (NYSE:XOM) -0.3% in Wednesday's trading as BNP Paribas Exane downgrades shares to Underperform from Neutral with ...
Fintel reports that on October 9, 2024, Exane BNP Paribas downgraded their outlook for Ciena (NYSE:CIEN) from Outperform to ...
On Tuesday, Welltower Inc (WELL) stock saw a decline, ending the day at $127.58 which represents a decrease of $-0.45 or -0.35% from the prior close of $128.03. The stock opened at $128.31 and touched ...
Hermes International is a way for investors to shield themselves from a short-term downturn in the luxury-goods sector, according to BNP Paribas Exane analysts, who upgraded the Birkin bag maker ...
Fintel reports that on October 8, 2024, Exane BNP Paribas initiated coverage of Dynatrace (NYSE:DT) with a Neutral recommendation. As of September 25, 2024, the average one-year price target for ...
Fintel reports that on October 8, 2024, Exane BNP Paribas initiated coverage of Datadog (NasdaqGS:DDOG) with a Outperform recommendation. As of September 24, 2024, the average one-year price ...
On Friday, Cloudflare Inc (NET) stock saw a modest uptick, ending the day at $93.47 which represents a slight increase of $1.01 or 1.09% from the prior close of $92.46. The stock opened at $92.94 and ...
(Bloomberg) -- Deutsche Post AG shares got their first sell-equivalent rating in six months as BNP Paribas Exane said analysts may need to slash earnings estimates for the German logistics group.
These three top-ranked, best-performing and well-managed funds can help you maximize your retirement portfolio returns. You might want to consider adding these three top-ranked, best-performing ...
Exane BNP Paribas (OTC:BNPQY) began coverage on SEB SA (SK:FP), assigning the stock an Outperform rating and setting a price target of EUR 125.00. The firm highlighted the stock's year-to-date decline ...
Exxon Mobil (NYSE:XOM) -0.3% in Wednesday's trading as BNP Paribas Exane downgrades shares to Underperform from Neutral with a $105 price target, getting its first Sell equivalent rating in more ...